SHIMIZU Yuko
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Professor
Article types Original article
Language English
Peer review Peer reviewed
Title Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
Journal Formal name:Lancet
Abbreviation:Lancet
ISSN code:01406736/1474547X
Domestic / ForeginForegin
Publisher 391(10127):1263-1273.
Volume, Issue, Page 391,pp.1263-1273
Author and coauthor Kappos L, Bar-Or A , Cree BA, Fox RJ , Giovannoni G , Gold R , Vermersch P, Arnold DL, Arnould S , Scherz T,Wolf C , Wallström E , Dahlke F,Gudesblatt M, Guillaume D, Haas J, Hancinova V, Hancu A ,Hardiman O, Harmjanz A, Heidenreich FR, Hengstman GJD, Herbert J, Herring M, Hodgkinson S, Hoffmann OM, Hofmann WE, Honeycutt WD, Hua LH, Huang D, Huang Y, Huang D, Hupperts R, Imre P, Jacobs AK, Jakab G, Jasinska E, Kaida K, Kalnina J, Kaprelyan A, Rodriguez JM, Rog D, Roshanisefat H, Rowe V, Rozsa C, Rubin S, Rusek S, Saccà F, Saida T, Salgado AV, Sanchez VEF, Sanders K, Satori M, Sazonov DV, Scarpini EA, Schlegel E, Schluep M, Schmidt S, Scholz E, Schrijver HM, Schwab M, Schwartz R, Scott J, Selmaj K, Shafer S, Sharrack B, Shchukin IA, Shimizu Y, et al.
Publication date 2018/03/22
DOI 10.1016/S0140-6736(18)30475-6
PMID 29576505